KCG
CASI

Knight Capital Group’s CASI Pharmaceuticals CASI Stock Holding History

Knight Capital Group’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$21K Buy
+1,041
New +$20.2K ﹤0.01% 3174

Other funds holding CASI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return

Knight Capital Group's CASI Position: Q2 2013 in Review

Knight Capital Group opened a new position in CASI Pharmaceuticals (CASI) in Q2 2013: 1,041 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings.

26 funds tracked by Wall St. Rank hold CASI as of Q2 2013.

  • Knight Capital Group held 1,041 shares of CASI Pharmaceuticals worth $21K as of Q2 2013.
  • CASI Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
  • CASI Pharmaceuticals made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3174 holding.
  • 26 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.